publication date 2011-05

• WHO Recommendations for the production, control and regulation of human plasma for fractionation
• Securing Safe Plasma for Fractionation the Duty of any Country
• Pathogen Reduction of Plasma
• Plasma Fractionation Industry Project in Turkey: Country’s Experiences
• Patients Perspective in Plasma Products (Focus on Hemophilia)
• Clinical application of plasma derived medicines: current situation and future trend
• Access and Rational use of Plasma Protein Therapies (PPTs)
• Hyperimmunes Plasma Procurement and Products
• Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation
• Plasma derived versus biotechnological manufactured medicine
• Making plasma derived medicines available
• Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines
• Plasma Fractionation in Malaysia
• Self Sufficiency In Plasma And Plasma Derived Medicines
• Message of President of ISBT to 2nd International Conference on Transfusion Medicine/Plasma Industry in Tehran, Iran, May 10-11, 2011